Patents Assigned to LivTech Inc. — Teikyo University Biotechnology Research Center
  • Anti-hDlk-1 antibody having an antitumor activity in vivo
    Patent number: 8017118
    Abstract: The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: September 13, 2011
    Assignee: LivTech Inc. — Teikyo University Biotechnology Research Center
    Inventors: Koji Nakamura, Rie Tajima, Shankar Kumar, J. Yun Tso, Naoya Tsurushita